Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders

A Zhang, JL Neumeyer, RJ Baldessarini - Chemical reviews, 2007 - ACS Publications
Dopamine (DA) is a critical neurotransmitter in the mammalian central nervous system
(CNS). The cerebral dopaminergic system is implicated in the pathophysiology of several …

Benzotriazole: An overview on its versatile biological behavior

I Briguglio, S Piras, P Corona, E Gavini… - European Journal of …, 2015 - Elsevier
Discovered in late 1960, azoles are heterocyclic compounds class which constitute the
largest group of available antifungal drugs. Particularly, the imidazole ring is the chemical …

CH–π hydrogen bonds in biological macromolecules

M Nishio, Y Umezawa, J Fantini, MS Weiss… - Physical Chemistry …, 2014 - pubs.rsc.org
This is a sequel to the previous Perspective “The CH–π hydrogen bond in chemistry.
Conformation, supramolecules, optical resolution and interactions involving carbohydrates” …

Visible‐Light Photoswitchable Benzimidazole Azo‐Arenes as β‐Arrestin2‐Biased Selective Cannabinoid 2 Receptor Agonists

SAM Steinmüller, J Fender… - Angewandte Chemie …, 2023 - Wiley Online Library
The cannabinoid 2 receptor (CB2R) has high therapeutic potential for multiple pathogenic
processes, such as neuroinflammation. Pathway‐selective ligands are needed to overcome …

Arylazobenzimidazoles: versatile visible-light photoswitches with tuneable Z-isomer stability

SAM Steinmüller, M Odaybat, G Galli, D Prischich… - Chemical …, 2024 - pubs.rsc.org
Benzimidazole heterocycles are of great importance in medicinal chemistry due to their
applicability to a wide range of pharmacological targets, therefore representing a …

[PDF][PDF] Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders

N Ye, JL Neumeyer, RJ Baldessarini, X Zhen, A Zhang - Chem. Rev, 2013 - academia.edu
Dopamine (DA) is a critical neurotransmitter in the mammalian central nervous system
(CNS). The cerebral dopaminergic system is implicated in the pathophysiology of several …

Identification of Novel Dopamine D2 Receptor Ligands—A Combined In Silico/In Vitro Approach

L Zell, C Lainer, J Kollár, V Temml, D Schuster - Molecules, 2022 - mdpi.com
Diseases of the central nervous system are an alarming global problem showing an
increasing prevalence. Dopamine receptor D2 (D2R) has been shown to be involved in …

Synthesis of some urea and thiourea derivatives of 3-phenyl/ethyl-2-thioxo-2, 3-dihydrothiazolo [4, 5-d] pyrimidine and their antagonistic effects on haloperidol …

F Azam, IA Alkskas, MA Ahmed - European journal of medicinal chemistry, 2009 - Elsevier
A series of 3-phenyl/ethyl-2-thioxo-2, 3-dihydrothiazolo [4, 5-d] pyrimidin-7-yl urea and
thiourea derivatives were designed and synthesized. All the compounds have been …

Dual ligands targeting dopamine D2 and serotonin 5-HT1A receptors as new antipsychotical or anti-Parkinsonian agents

N Ye, Z Song, A Zhang - Current Medicinal Chemistry, 2014 - ingentaconnect.com
Psychiatric disorders like schizophrenia and neurodegenerative diseases like Parkinson's
disease are associated with poly-factorial pathogenic mechanisms, with several …

In silico studies targeting G-protein coupled receptors for drug research against Parkinson's disease

A Lemos, R Melo, AJ Preto, JG Almeida… - Current …, 2018 - ingentaconnect.com
Parkinson's Disease (PD) is a long-term neurodegenerative brain disorder that mainly
affects the motor system. The causes are still unknown, and even though currently there is …